z-logo
open-access-imgOpen Access
Relative Dose Intensity and Pathologic Response Rates in Patients With Breast Cancer and With and Without HIV Who Received Neoadjuvant Chemotherapy
Author(s) -
Yehoda M. Martei,
Mohan Narasimhamurthy,
Dipho I. Setlhako,
Gezahen Negusse Ayane,
Tlotlo Ralefala,
Sebathu Chiyapo,
Robert Gross,
Lawrence N. Shulman,
Surbhi Grover,
Angela DeMichele
Publication year - 2022
Publication title -
jco global oncology
Language(s) - English
Resource type - Journals
ISSN - 2687-8941
DOI - 10.1200/go.22.00016
Subject(s) - medicine , hazard ratio , breast cancer , chemotherapy , zidovudine , odds ratio , gastroenterology , prospective cohort study , oncology , cancer , human immunodeficiency virus (hiv) , confidence interval , immunology , viral disease

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom